Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for eradication of vancomycin-resistant Enterococcus carriage
NL-OMON25381Phase 2Not yet recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2018
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of allogeneic fecal microbiota in Enterococcus colonization, sponsored by University Medical Center Utrecht. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Enterococcus colonization
Beyond the preview
Go deeper on NL-OMON25381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25381.